Abbott Laboratories Stock Today

ABT Stock  USD 106.76  0.50  0.47%   


0 of 100

Very Weak

Odds Of Distress

Less than 5

Very Low
Abbott Laboratories is selling for under 106.76 as of the 25th of July 2024; that is 0.47 percent down since the beginning of the trading day. The stock's last reported lowest price was 106.76. Abbott Laboratories has under 5 % chance of experiencing financial distress over the next 2 years, but has generated negative returns over the last 90 days. Note, on February 6, 2024, Representative Kathy Manning of US Congress acquired under $15k worth of Abbott Laboratories's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
13th of January 1978
Health Care
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.74 B outstanding shares of which 13 M shares are presently shorted by investors with about 2.17 days to cover. More on Abbott Laboratories

Moving together with Abbott Stock

  0.67CI Cigna CorpPairCorr
  0.64DH Definitive HealthcarePairCorr

Moving against Abbott Stock

  0.47GH Guardant HealthPairCorr
  0.43OM Outset MedicalPairCorr
  0.41DOCS DoximityPairCorr
  0.34EMBC Embecta Corp TrendingPairCorr

Abbott Stock Highlights

ESG Sustainability
CEORobert Ford
Thematic Ideas
(View all Themes)
Old Names[Absolute Software Corporation, Abbott Laboratories, Aqua Bio Technology ASA, Abundant Produce Limited, Abbott Laboratories]
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, SP 100 Index, SP 100, NYSE 100 Index, ARCA Institutional, BTRINVSTNG 100 INDEX, BETTERINVESTING 100 INDEX, VN Index, Compulsion, SRI Sustainable Growth, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.120.0782
Way Up
Very volatile
Asset Turnover0.840.5478
Way Up
Pretty Stable
Gross Profit Margin0.620.5518
Moderately Up
Pretty Stable
Net Debt6.1 BB
Way Down
Slightly volatile
Total Current Liabilities8.3 B13.8 B
Way Down
Slightly volatile
Non Current Liabilities Total11.7 B20.5 B
Way Down
Slightly volatile
Total Assets36.9 B73.2 B
Way Down
Slightly volatile
Total Current Assets13.3 B22.7 B
Way Down
Pretty Stable
Total Cash From Operating Activities5.2 B7.3 B
Way Down
Slightly volatile
Debt Levels
Abbott Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Abbott Laboratories' financial leverage. It provides some insight into what part of Abbott Laboratories' total assets is financed by creditors.
Abbott Laboratories has 15.87 B in debt with debt to equity (D/E) ratio of 0.46, which is OK given its current industry classification. Abbott Laboratories has a current ratio of 1.82, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Abbott to invest in growth at high rates of return.

Other Non Cash Items

9.06 Billion
Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 and employs 114,000 people. Abbott Laboratories is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 180.78 B. Abbott Laboratories runs under Health Care Equipment & Supplies sector within Health Care industry. The entity has 1.74 B outstanding shares of which 13 M shares are presently shorted by investors with about 2.17 days to cover. Abbott Laboratories has about 9.88 B in cash with 7.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.68.
Check Abbott Laboratories Probability Of Bankruptcy
Ownership Allocation
Abbott Laboratories holds a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that on February 6, 2024, Representative Kathy Manning of US Congress acquired under $15k worth of Abbott Laboratories's common stock.
Check Abbott Ownership Details

Abbott Stock Institutional Holders

InstituionRecorded OnShares
Polen Capital2024-03-31
16.1 M
Bank Of New York Mellon Corp2024-03-31
14.8 M
Legal & General Group Plc2024-03-31
14.2 M
Jpmorgan Chase & Co2024-03-31
14.1 M
State Farm Mutual Automobile Ins Co2024-03-31
13.6 M
Charles Schwab Investment Management Inc2024-03-31
12.4 M
Nuveen Asset Management, Llc2024-03-31
10.9 M
Massachusetts Financial Services Company2024-03-31
10.8 M
Bank Of America Corp2024-03-31
10.7 M
Vanguard Group Inc2024-03-31
165.3 M
Blackrock Inc2024-03-31
133.1 M
View Abbott Laboratories Diagnostics

Abbott Laboratories Historical Income Statement

At this time, Abbott Laboratories' Depreciation And Amortization is comparatively stable compared to the past year. EBITDA is likely to gain to about 11.1 B in 2024, whereas Total Revenue is likely to drop slightly above 22.2 B in 2024. View More Fundamentals

Abbott Stock Against Markets

Abbott Laboratories Corporate Directors

Samuel ScottIndependent DirectorProfile
Nancy McKinstryIndependent DirectorProfile
Phebe NovakovicIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile

Already Invested in Abbott Laboratories?

The danger of trading Abbott Laboratories is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.